Frontiers in Oncology (Apr 2024)

Editorial: Overcoming obstacles of cancer immunotherapy: the important role of emerging nanomedicine

Aimin Jiang,
Wangxiao He,
Wangxiao He,
Yu Yao

Affiliations

Aimin Jiang: Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
Wangxiao He: Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
Wangxiao He: Department of Talent Highland, The First Affiliated Hospital of Xi’an Jiao Tong University, Xi’an, China
Yu Yao: Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

DOI: https://doi.org/10.3389/fonc.2024.1406244
Journal volume & issue: Vol. 14

Abstract

No abstracts available.

Published in Frontiers in Oncology

ISSN: 2234-943X (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.frontiersin.org/journals/oncology/

About the journal